Drug Profile
Research programme: CNS-targeted monoclonal antibodies - Genmab
Alternative Names: CNS-mAB - Genmab; CNS-monoclonal antibodies - GenmabLatest Information Update: 10 Nov 2010
Price :
$50
*
At a glance
- Originator Genmab
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Brain cancer; Brain disorders